The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) is a partnership between the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP) Association whose members are several EU Member States and Associated countries and several African countries. Apply below
15th February 2022.
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) builds on the first and second European and Developing Countries Clinical Trials Partnership programmes. This new joint undertaking is a partnership between the EU and the EDCTP Association, whose members are several European and African countries.
To decide on its scientific priorities and achieve its objectives, the GH EDCTP3 is to be advised by a Scientific Committee and other advisory bodies. The call for expression of interest for the selection of the members of the Scientific Committee is now open and will close on 15 February 2022.
Building on the positive experience of the previous EDCTP programmes, the GH EDCTP3 JU intends to:
The Scientific Committee of the GH EDCTP3 JU has the following tasks:
(a) advise on the scientific priorities to be addressed in the work programmes including on scope of calls for proposals, in line with the Strategic Research and Innovation Agenda and the Horizon Europe strategic planning;
(b) advise on the scientific achievements to be described in the annual activity report;
(c) suggest, in view of the progress of the Strategic Research and Innovation Agenda and individual actions, corrective measures or re-orientations to the governing board, where necessary;
(d) provide independent advice and scientific analysis on specific issues as requested by the governing board, in particular as regards developments in adjacent sectors or to support the assessment of applications of potential associated members and contributing partners;
(e) assist in the design of the strategic and scientific planning of the activities of the Global Health EDCTP3 Joint Undertaking;
(f) advise on strategies to foster synergies and partnerships with all stakeholders;
(g) contribute to the preparation of strategic and scientific documents relevant to the Global Health EDCTP3 Joint Undertaking, as required;
(h) provide strategic and scientific advice to the Global Health EDCTP3 Joint Undertaking and ensure the successful completion of on-going projects;
(i) identify strategic needs and priorities for accelerating the development of new or improved clinical interventions, including the required training, networking and capacity building to be undertaken to achieve those objectives;
(j) review the landscape of poverty-related and neglected diseases to identify the Global Health EDCTP3 Joint Undertaking’s role in partnership with other stakeholders to accelerate the development or improvement of interventions against those diseases;
(k) assess the state of global product development pathways and the critical path opportunities for future product development;
(l) provide advice on the review of any calls for proposals and other programmes;
(m)provide support and input on the monitoring and evaluation framework of the Global Health EDCTP3 Joint Undertaking, as well as in the monitoring of scientific outcomes and strategic impacts of the grants funded by the Global Health EDCTP3 Joint Undertaking;
(n) advise, assist and participate in Global Health EDCTP3 Joint Undertaking working groups, stakeholder meetings, EDCTP Forum and other relevant events.
The Governing Board of the GH EDCTP3 JU will take the following criteria into account when assessing applications:
Candidate Members of the Scientific Committee shall meet the following essential eligibility criteria:
• University degree in a relevant scientific area, preferably at post-graduate level;
• At least five years of professional experience in the relevant scientific area after having obtained the above mentioned degree;
Candidate Members of the Scientific Committee shall meet the following specific eligibility criteria:
In addition, a record of previous participation in other scientific and/or technological advisory bodies, demonstrating the ability to look for consensus and to provide synthetic, wide-spectrum analyses would be considered an asset.
European Commission staff, including external staff working for the Commission, staff of the Joint Research Centre, officials of Member States, and of national, regional or local authorities shall not be eligible.
Persons who are employed by an organisation that is member of the Global Health EDCTP3 Joint Undertaking or who are employed directly by the Joint Undertaking shall not be eligible.
The Global Health EDCTP3 Joint Undertaking shall reserve the right to request any necessary documentary evidence it deems fit and relevant in order to verify the applicants’ skills and knowledge.
The same rules on appointment, reimbursement of costs and allowances, applicable to external experts according to the rules of the European Commission shall apply to the members of the Scientific Committee.
The Governing Board of the GH EDCTP3 JU shall appoint the members of the Scientific Committee for a three year period. They shall remain in office until replaced or until the end of their term of office, whichever is earlier. Upon recommendation by the Executive Director, the Governing Board may decide to renew the appointment for an additional period of two years.
The approved reserve list shall be valid for the duration of the term, including any subsequent renewal, of the appointed Scientific Committee. In case of a vacancy, the Governing Board shall, subject to continuing eligibility in terms of the criteria presented in section 5, select a new member from the reserve list for a period of three years or for the rest of the duration of the term of the Scientific Committee, whichever is the shortest.
Applications must be completed in one of the official languages of the European Union.
However, applications in English would facilitate the evaluation procedure. If another language is used, it would be helpful to include a summary of the application in English.
An application will be deemed admissible only if it is sent by the deadline and includes:
• A cover letter explaining the candidate’s motivation for applying and how the applicant fulfulls the criteria set out below.
• A curriculum vitae (CV)
The duly signed applications must be sent by 15 February 2022 23:59:00 hrs at the latest to the following e-mail address:
The date of the e-mail will be the date of sending.